The interferon gamma pathway, which affects tumor progression and regression in different cancers (Jorgovanovic et al., 2020) and also metabolic signalings (Siska and Rathmell, 2016), showed significantly different GSVA scores between the two subpopulations with different survival times in the second module shown in Figures 7D, 8G. This evidence concerns the gene IFNG and neoplasm.